| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.3 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |